5-Year Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure ― Japanese Cohort ―
Takura Taguchi(Osaka University Hospital), Shigeru Miyagawa(The University of Osaka), Yusuke Yanagino(National Cerebral and Cardiovascular Center), Takuji Kawamura(The University of Osaka), Naonori Kawamoto(National Cerebral and Cardiovascular Center), Naoki Tadokoro(National Cerebral and Cardiovascular Center), Takashi Kakuta(National Cerebral and Cardiovascular Center), Shin Yajima(National Cerebral and Cardiovascular Center), Ai Kawamura(The University of Osaka), Yasuhiro Akazawa(The University of Osaka), Yasumasa Tsukamoto(National Cerebral and Cardiovascular Center), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Yasushi Sakata(Osaka University), Nana Kitahata(National Cerebral and Cardiovascular Center), Kota Suzuki(The University of Osaka), Yusuke Misumi(The University of Osaka), Kohei Tonai(National Cerebral and Cardiovascular Center), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Takuya Watanabe(National Cerebral and Cardiovascular Center), Daisuke Yoshioka(The University of Osaka), Hiroki Mochizuki(National Cerebral and Cardiovascular Center), Shunsuke Saito(The University of Osaka)
Cited by 1
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
|Circulation Journal|2021|115
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
|Frontiers in Cardiovascular Medicine|2022|106